DC Bar
Proud Sponsor of the Organization of Women in International Trade - Badge
Virginia State Bar

FTC Chairman Ferguson Launches Healthcare Task Force for Coordinated Enforcement and Advocacy

Andre Barlow

Chairman Ferguson Launches Healthcare Task Force for Coordinated Enforcement and Advocacy

On March 20, 2026, Federal Trade Commission Chairman Andrew N. Ferguson directed staff to form a Healthcare Task Force. The initiative is designed to take a coordinated, integrated approach to competition and consumer-protection enforcement and advocacy across the healthcare sector, with the stated goal of protecting patients, healthcare workers, and taxpayers. It aligns with President Trump’s executive order directing efforts to create a more competitive, innovative, affordable, and higher-quality healthcare system.

Structure and Mandate

In a memorandum to bureau and office leadership, Chairman Ferguson instructed the Bureaus of Competition, Consumer Protection, and Economics, together with the Office of Policy Planning and the Office of Technology, to establish the Task Force. The group will be co-chaired by one representative each from the Bureau of Competition and the Bureau of Consumer Protection, with additional members from each bureau and from the Offices of Policy Planning, Technology, and General Counsel. It is expected to meet monthly and report to the Chairman quarterly.

The Task Force’s core functions include:

  • Leading targeted enforcement and advocacy initiatives focused on key priorities;
  • Developing coordinated, agency-wide strategies for investigations;
  • Taking a proactive approach to identifying opportunities for amicus briefs and statements of interest; and
  • Conducting horizon-scanning to identify emerging issues and new priority areas for enforcement and advocacy.

The Task Force will also seek to expand its membership and collaboration to include other federal partners, notably the Department of Health and Human Services and the Department of Justice. Through this structure, the agency intends to share knowledge, market intelligence, case leads, and resources across its dual competition and consumer-protection mandates.

Recent Enforcement Context

The announcement frames the Task Force as a continuation and institutionalization of the FTC’s recent healthcare work. The agency highlighted several actions from the prior year, including a landmark settlement with Express Scripts requiring practice changes expected to lower patients’ out-of-pocket drug costs (including for insulin) by up to $7 billion over ten years; a successful challenge to Edwards’ proposed acquisition of JenaValve that preserved competition on innovation and product quality; the abandonment of the proposed Alcon-Lensar merger of cataract-surgery device makers, preserving competition on price and innovation; securing $145 million in consumer redress from companies alleged to have misled consumers seeking health insurance; and action against substance-abuse treatment facilities that used deceptive telemarketing practices, yielding $2.4 million in redress.

These examples illustrate the range of issues—pharmacy-benefit-manager practices, medical-device mergers, consumer deception in insurance and treatment marketing—that the Task Force is intended to address in a more coordinated fashion.

Implications

By creating a cross-bureau structure with an explicit interagency component, the Healthcare Task Force signals that healthcare will remain a sustained priority under the current Commission. The emphasis on coordinated investigative strategies, proactive amicus work, and identification of emerging issues suggests both continued scrutiny of traditional competition concerns (such as provider and device mergers) and expanded attention to consumer-protection problems involving pricing transparency, marketing, and data practices. The invitation to partner with HHS and the Department of Justice further indicates that healthcare stakeholders may encounter coordinated federal inquiries that draw on multiple agencies’ authorities.

For hospitals, physician groups, pharmacy-benefit managers, device manufacturers, and other industry participants, the formation of the Task Force reinforces the value of early assessment of antitrust and consumer-protection risk and of preparing for a more integrated enforcement posture across the federal government. The initiative institutionalizes the FTC’s dual-mandate approach to healthcare and positions the agency to act more systematically on both existing and emerging issues in the sector.

Andre Barlow

abarlow@dbmlawgroup.com

Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.